Smallcap Pharma Company NGL Fine Chem Sees 7.04% Stock Increase, Outperforms Sector and Market

NGL Fine Chem, a smallcap pharmaceutical company, saw a 7.04% increase in its stock price on August 12, 2024. This rise in stock value was reflected in the stock call given by MarketsMOJO, which rated NGL Fine Chem as a 'Hold'.

The stock's performance today was particularly noteworthy as it outperformed the sector by 5.48%. It also reached an intraday high of Rs 2700, showing a 7.89% increase. This positive trend is further supported by the fact that NGL Fine Chem is currently trading higher than its 5-day, 20-day, 50-day, 100-day, and 200-day moving averages.

In comparison to the overall market performance, NGL Fine Chem has shown a strong 1-day performance of 6.64%, while the Sensex only saw a 0.17% increase. Over the past month, NGL Fine Chem has also outperformed the Sensex with a 3.51% increase, while the Sensex saw a decrease of -0.84%.

NGL Fine Chem's consistent performance and positive stock movement make it a promising player in the pharmaceutical industry. With its strong performance and steady growth, NGL Fine Chem is definitely a company to keep an eye on in the smallcap market.